Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Astellas_Pharma
|
| gptkbp:acquisitionYear |
2018
|
| gptkbp:foundedBy |
gptkb:John_A._Stamatoyannopoulos
Claudia Mitchell David J. Rawlings Richard G. James |
| gptkbp:foundedYear |
2013
|
| gptkbp:headquartersLocation |
gptkb:Seattle,_Washington,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Universal Cells
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
universal donor stem cells
|
| gptkbp:specializesIn |
gene editing
stem cell technology |
| gptkbp:technology |
gene editing using homologous recombination
|
| gptkbp:website |
https://universal-cells.com/
|
| gptkbp:bfsParent |
gptkb:Astellas_Pharma_Inc.
|
| gptkbp:bfsLayer |
7
|